Virtual biology company Turbine has raised $25 million in a Series B funding round. The new investment will help the company grow its virtual cell technology and expand into immunology. This marks a big step for Turbine as it moves beyond its initial focus on oncology research. Funding Highlights and Investor Support The funding round










